Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 2 (February)

1. Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.
   Br J Surg, 93(2): 243-9. [Abstract] [Full-text]
2. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice.
   Int J Cancer, 118(4): 932-41. [Abstract] [Full-text]
3. Increase in skin cancer screening during a community-based randomized intervention trial.
   Int J Cancer, 118(4): 1010-6. [Abstract] [Full-text]
4. Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma.
   J Clin Oncol, 24(5): 798-804. [Abstract] [Full-text]
5. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
   Arch Ophthalmol, 124(2): 226-38. [Abstract] [Full-text]
6. Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion.
   Cancer Chemother Pharmacol, 57(5): 584-90. [Abstract] [Full-text]
7. Prognostic significance of autoimmunity during treatment of melanoma with interferon.
   N Engl J Med, 354(7): 709-18. [Abstract] [Full-text]
8. Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
   Arch Dermatol, 142(2): 166-72. [Abstract] [Full-text]
9. Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial.
   Br J Cancer, 94(4): 492-8. [Abstract] [Full-text]
10. Superiority of a cognitive education with photographs over ABCD criteria in the education of the general population to the early detection of melanoma: a randomized study.
    Int J Cancer, 118(9): 2276-80. [Abstract] [Full-text]
11. p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.
    Int J Cancer, 118(9): 2262-8. [Abstract] [Full-text]
12. Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma.
    J Clin Oncol, 24(7): 1188-94. [Abstract] [Full-text]
13. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
    J Clin Oncol, 24(7): 1178-87. [Abstract] [Full-text]
14. Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.
    J Clin Oncol, 24(7): 1169-77. [Abstract] [Full-text]
15. Sentinel lymph node biopsy in thin melanoma patients.
    J Surg Oncol, 93(4): 279-85. [Abstract] [Full-text]
16. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Int J Radiat Oncol Biol Phys, 64(4): 1018-22. [Abstract] [Full-text]
17. Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion.
    Int Immunopharmacol, 6(4): 697-702. [Abstract] [Full-text]
18. ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank.
    Cancer Immunol Immunother, 55(6): 623-7. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.